Skip to main content

David Aluja Gonzalez

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

David Aluja Gonzalez

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Personal Investigador para Grupo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Personal Investigador para Grupo Cardiovascular, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00758
Duration: 01/01/2022 - 30/06/2025

ROLE OF CALPAINS AND REPROGRAMMING OF ESSENTIAL AMINO ACID METABOLISM IN VENTRICULAR HYPERTROPHY AND HEART FAILURE

IP: José Antonio Barrabés Riu
Collaborators: Rafael Rodríguez Lecoq, Mª Teresa Pastor Amorós, David Aluja Gonzalez, Vicente Serra García, Natalia Gonzalez Otero, Javier Inserte Igual
Funding agency: Instituto de Salud Carlos III
Funding: 148225
Reference: PI20/01681
Duration: 01/01/2021 - 31/12/2024

Deficiencia de hierro en pacientes con infarto agudo de miocardio: efecto durante la fase aguda y el remodelado ventricular y caracterización en un modelo animal de los mecanismos implicados.

IP: José Antonio Barrabés Riu
Collaborators: Elsa Nieto Santa, Rosa María Lidón Corbi, David Aluja Gonzalez, Javier Inserte Igual
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI16/00232
Duration: 01/01/2017 - 30/09/2020

La inhibició de les proteases calpaines com estratègia farmacològica en el tractament del remodelat ventricular

IP: -
Collaborators: David Aluja Gonzalez, Miriam Izquierdo Sans
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-2015-26
Duration: 01/03/2016 - 28/02/2019

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into clinical practice.

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

Related professionals

Judith Sacanell Lacasa

Judith Sacanell Lacasa

Shock, Organ Dysfunction and Resuscitation
Read more
Sara Palacin i Bonson

Sara Palacin i Bonson

Research technician
Neurodegenerative Diseases
Read more
Susana Anfosso Llopis

Susana Anfosso Llopis

Infectious Diseases
Read more
Marta Vallvé Odena

Marta Vallvé Odena

Teaching Unit
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.